Global Point-of-care Molecular Diagnostics Market

Global Point-of-care Molecular Diagnostics Market Size, Trends, and Analysis - Forecasts To 2026 By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications), By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Test Location (Over-the-Counter, POC), By End-User (Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Other Uses), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on December 20 2024 with the latest and most recent market numbers

Point-of-care Molecular Diagnostics Market: Insights

Point-of-care molecular diagnostics are diagnostic tests carried out to study and analyze the biological markers in the genome and proteome, cell expressions of genes as proteins through the use of molecular biology techniques. The growing demand for faster and more accurate diagnostic techniques is expected to be the major driver of the point-of-care molecular diagnostics market. Molecular diagnostics incorporates novel molecular biology aspects to biological testing to improve existing techniques and develop new techniques and methods. Point-of-care molecular testing allows doctors to diagnose patients quickly and begin treatment as soon as possible without much delay. Molecular diagnostics cuts down on the waiting time for results which can often be days. With the growing need for early detection, healthcare facilities had focused extensively on developing new molecular testing techniques rather than finding a cure which has contributed to the growth of the point-of-care molecular diagnostics market. Single gene disease diagnosis and multi-gene diagnosis through mutation-specific targeted analysis with the help of portable sequence analysis platforms have been developed in recent years. Large investments in the development of molecular testing in the previous decade are expected to result in newer testing techniques which will result in the growth of the point-of-care molecular diagnostics market. The growing availability of skilled personnel is expected to positively impact the growth of the point-of-care molecular diagnostics market. The COVID-19 pandemic has also resulted in new techniques being developed by vendors. Abbott developed a point-of-care molecular diagnostic test for detecting the coronavirus within five minutes. The growing expenditure on healthcare and initiatives to provide healthcare to underprivileged sections of the society by governments across the world are also expected to have an impact on the growth of the point-of-care molecular diagnostics market.

global point-of-care molecular diagnostics market

Point-of-care Molecular Diagnostics Market: By Application

Based on the application of molecular diagnostics, the point-of-care molecular diagnostics market can be segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. The infectious diseases segment is expected to hold the largest share of the market during the forecast period. Growing incidences of infectious diseases have been the major driver of the infectious diseases segment. Molecular diagnosis of infectious diseases has various advantages like ensuring faster disease management, reduction in mortality rates, lower costs, timely provision of antimicrobial treatments, and better distribution of laboratory assets. The oncology segment is expected to grow at the fastest rate during the forecast period. The major drivers of the oncology segment have been the growing number of people suffering from cancer, and the developments occurring within molecular diagnostics for oncology.

Point-of-care Molecular Diagnostics Market: By Technology

Based on the various point-of-care molecular diagnostics technologies available in the market, the point-of-care molecular diagnostics market can be segmented into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based tests and devices. The PCR-based segment is expected to hold the lion’s share of the market during the forecast period. The rapid commercialization of PCR-based tests has resulted in the dominance of the PCR-based segment. PCR tests provide a highly reliable and accurate diagnosis of infectious diseases like influenza and H1N1 have also contributed to the dominance of this segment. The genetic sequencing-based segment is expected to grow at the fastest rate during the forecast period. Technplgovial developments and the release of novel products are expected to result in the growth of the genetic sequencing-based segment. New technological developments are expected to improve the accuracy and speed of the tests. Continued expenditure on research and development of new products is also expected to positively impact the growth of the genetic sequencing-based segment during the forecast period.

Point-of-care Molecular Diagnostics Market: By Test Location

Based on the location where the diagnosis or test can be conducted, the point-of-care molecular diagnostic market can be segmented into point-of-care (PoC) and over-the-counter test segments. The over-the-counter segment is expected to register the fastest growth rate. These tests are easy to administer and can be carried out by unskilled personnel and in most cases, the patients themselves can carry out these tests. The growing availability of such tests, their relative ease of access, lower costs, and increasing adoption rates are expected to result in the growth of the over-the-counter segment during the forecast period.

Point-of-care Molecular Diagnostics Market: By End-User

Based on the various end users, the point-of-care molecular diagnostics market can be segmented into decentralized laboratories, hospitals, homecare, assisted living healthcare facilities, and others. The decentralized laboratories are expected to hold the dominant share of the market during the forecast period. Point-of-care molecular diagnostics require lesser physical infrastructure and have been extensively undertaken by decentralized laboratories that are smaller than those laboratories that are attached to larger healthcare providers.

asia pacific point-of-care molecular diagnostics market

Point-of-care Molecular Diagnostics Market: By Region

The North American region is expected to hold the dominant share of the market during the forecast period. The growing number of clinical studies in the region to develop new molecular diagnostics combined with the heavy investment in healthcare facilities have resulted in the dominance of the North American region in the point-of-care molecular diagnostics market. The APAC region is expected to register the fastest growth rate during the forecast period. The growing demand for molecular diagnostics, growing number of decentralized laboratories in the region are expected to significantly increase the demand for the point-of-care molecular diagnostics market in the APAC region. The growing population and lower costs of point-of-care molecular diagnostics are also expected to contribute to the growth of the point-of-care molecular diagnostics market in the APAC region.

Point-of-care Molecular Diagnostics Market: Share & Competitor Analysis

Abbott Laboratories, Danaher Corporation, Johnson and Johnson, Cepheid, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bayer Healthcare, BioMerieux, among others, are the major vendors competing in the point-of-care molecular diagnostics market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Point of Care Molecular Diagnostics Industry Overview, 2019-2026

2.1.1 Industry Overview

2.1.2 Test Location Overview

2.1.3 Application Overview

2.1.4 End-User Overview

2.1.5 Technology Overview

2.1.6 Regional Overview

Chapter 3 Point of Care Molecular Diagnostics Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2019-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Technology Advancement in POC Molecular Test

3.3.1.2 Rising Prevalence of Infectious Disease

3.3.2 Industry Challenges

3.3.2.1 Lack of Adequate Infrastructure and Automated Laboratory Systems in Developing Nations

3.4 Prospective Growth Scenario

3.4.1 Test Location Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Technology Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Point of Care Molecular Diagnostics Market, By Test Location

4.1 Test Location Outlook

4.2 Over the Counter

4.2.1 Market Size, By Region, 2019-2026 (USD Million)

4.3 Point of Care

4.3.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 5 Point of Care Molecular Diagnostics Market, By Application

5.1 Application Outlook

5.2 Infectious Disease

5.2.1 Market Size, By Region, 2019-2026 (USD Million)

5.3 Oncology

5.3.1 Market Size, By Region, 2019-2026 (USD Million)

5.4 Haematology

5.4.1 Market Size, By Region, 2019-2026 (USD Million)

5.5 Prenatal Testing

5.5.1 Market Size, By Region, 2019-2026 (USD Million)

5.6 Endocrinology

5.6.1 Market Size, By Region, 2019-2026 (USD Million)

5.7 Other Applications

5.7.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 6 Point of Care Molecular Diagnostics Market, By End-User

6.1 Decentralized Labs

6.1.1 Market Size, By Region, 2019-2026 (USD Million)

6.2 Hospitals

6.2.1 Market Size, By Region, 2019-2026 (USD Million)

6.3 Home Care

6.3.1 Market Size, By Region, 2019-2026 (USD Million)

6.4 Assisted Living Healthcare Facilities

6.4.1 Market Size, By Region, 2019-2026 (USD Million)

6.5 Others

6.5.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 7 Point of Care Molecular Diagnostics Market, By Technology

7.1 PCR-Based

7.1.1 Market Size, By Region, 2019-2026 (USD Million)

7.2 Genetic Sequencing-Based

7.2.1 Market Size, By Region, 2019-2026 (USD Million)

7.3 Hybridization Based

7.3.1 Market Size, By Region, 2019-2026 (USD Million)

7.4 Microarray Based

7.4.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 8 Point of Care Molecular Diagnostics Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2019-2026 (USD Million)

8.2.2 Market Size, By Test Location, 2019-2026 (USD Million)

8.2.3 Market Size, By Application, 2019-2026 (USD Million)

8.2.4 Market Size, By End-User, 2019-2026 (USD Million)

8.2.5 Market Size, By Technology, 2019-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.2.4.2 Market Size, By Application, 2019-2026 (USD Million)

8.2.4.3 Market Size, By End-User, 2019-2026 (USD Million)

Market Size, By Technology, 2019-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.2.7.2 Market Size, By Application, 2019-2026 (USD Million)

8.2.7.3 Market Size, By End-User, 2019-2026 (USD Million)

8.2.7.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2019-2026 (USD Million)

8.3.2 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.3 Market Size, By Application, 2019-2026 (USD Million)

8.3.4 Market Size, By End-User, 2019-2026 (USD Million)

8.3.5 Market Size, By Technology, 2019-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.6.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.6.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.6.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.7.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.7.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.7.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.8.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.8.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.8.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.9.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.9.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.9.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.10.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.10.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.10.4 Market Size, By Technology, 2019-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.3.11.2 Market Size, By Application, 2019-2026 (USD Million)

8.3.11.3 Market Size, By End-User, 2019-2026 (USD Million)

8.3.11.4 Market Size, By Technology, 2019-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2019-2026 (USD Million)

8.4.2 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.3 Market Size, By Application, 2019-2026 (USD Million)

8.4.4 Market Size, By End-User, 2019-2026 (USD Million)

8.4.5 Market Size, By Technology, 2019-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.6.2 Market Size, By Application, 2019-2026 (USD Million)

8.4.6.3 Market Size, By End-User, 2019-2026 (USD Million)

8.4.6.4 Market Size, By Technology, 2019-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.7.2 Market Size, By Application, 2019-2026 (USD Million)

8.4.7.3 Market Size, By End-User, 2019-2026 (USD Million)

8.4.7.4 Market Size, By Technology, 2019-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.8.2 Market Size, By Application, 2019-2026 (USD Million)

8.4.8.3 Market Size, By End-User, 2019-2026 (USD Million)

8.4.8.4 Market Size, By Technology, 2019-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.9.2 Market size, By Application, 2019-2026 (USD Million)

8.4.9.3 Market Size, By End-User, 2019-2026 (USD Million)

8.4.9.4 Market Size, By Technology, 2019-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.4.10.2 Market Size, By Application, 2019-2026 (USD Million)

8.4.10.3 Market Size, By End-User, 2019-2026 (USD Million)

8.4.10.4 Market Size, By Technology, 2019-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2019-2026 (USD Million)

8.5.2 Market Size, By Test Location, 2019-2026 (USD Million)

8.5.3 Market Size, By Application, 2019-2026 (USD Million)

8.5.4 Market Size, By End-User, 2019-2026 (USD Million)

8.5.5 Market Size, By Technology, 2019-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.5.6.2 Market Size, By Application, 2019-2026 (USD Million)

8.5.6.3 Market Size, By End-User, 2019-2026 (USD Million)

8.5.6.4 Market Size, By Technology, 2019-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.5.7.2 Market Size, By Application, 2019-2026 (USD Million)

8.5.7.3 Market Size, By End-User, 2019-2026 (USD Million)

8.5.7.4 Market Size, By Technology, 2019-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.5.8.2 Market Size, By Application, 2019-2026 (USD Million)

8.5.8.3 Market Size, By End-User, 2019-2026 (USD Million)

8.5.8.4 Market Size, By Technology, 2019-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2019-2026 (USD Million)

8.6.2 Market Size, By Test Location, 2019-2026 (USD Million)

8.6.3 Market Size, By Application, 2019-2026 (USD Million)

8.6.4 Market Size, By End-User, 2019-2026 (USD Million)

8.6.5 Market Size, By Technology, 2019-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.6.6.2 Market Size, By Application, 2019-2026 (USD Million)

8.6.6.3 Market Size, By End-User, 2019-2026 (USD Million)

8.6.6.4 Market Size, By Technology, 2019-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.6.7.2 Market Size, By Application, 2019-2026 (USD Million)

8.6.7.3 Market Size, By End-User, 2019-2026 (USD Million)

8.6.7.4 Market Size, By Technology, 2019-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Test Location, 2019-2026 (USD Million)

8.6.8.2 Market Size, By Application, 2019-2026 (USD Million)

8.6.8.3 Market Size, By End-User, 2019-2026 (USD Million)

8.6.8.4 Market Size, By Technology, 2019-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 Abbott Laboratories

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 Danaher Corporation

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Johnson and Johnson

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Cepheid, Inc.

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 F. Hoffmann-La Roche AG

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Becton, Dickinson and Company

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 Bio-Rad Laboratories

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Bayer Healthcare

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 BioMerieux

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

The Global Point-of-care Molecular Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Point-of-care Molecular Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.